Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
April 25, 2024 07:00 ET
|
Optinose, Inc.
YARDLEY, Pa., April 25, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
MamaMancini’s Announces Estimated Record Preliminary Revenues and Net Income for Fiscal First Quarter 2021
April 29, 2020 08:31 ET
|
MamaMancini's Holdings, Inc.
Company Donates the Equivalent of 15,000 meals to Bridges Outreach, Inc. and GRACE to Support Local Community Affected by COVID-19 EAST RUTHERFORD, NJ, April 29, 2020 (GLOBE NEWSWIRE) --...